La plexite radique : épidémiologie, diagnostic, facteurs de risque et prise en charge

Autor: C. Miran, E. Bonnet, C. Lafont, P. Baseilhac, S. Clippe, M. El Hedi Zouai, J. Langrand-Escure, M. Bosset, B. Fleury, J.-B. Guy

Publikováno v: Cancer/Radiothérapie. 27:163-169

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7759656934e80c658c8e91207a065dc0
https://doi.org/10.1016/j.canrad.2022.06.010

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey

Autor: F, Vilotte, D, Pasquier, P, Blanchard, S, Supiot, J, Khalifa, U, Schick, T, Lacornerie, L, Vieillevigne, D, Marre, O, Chapet, I, Latorzeff, N, Magne, E, Meyer, K, Cao, Y, Belkacemi, J E, Bibault, M, Berge-Lefranc, J C, Faivre, K, Gnep, V, Guimas, A, Hasbini, J, Langrand-Escure, C, Hennequin, P, Graff

Publikováno v: Clinical and translational radiation oncology. 37

The relevance of metastasis-directed stereotactic body radiation therapy (SBRT) remains to be demonstrated through phase III trials. Multiple SBRT procedures have been published potentially resulting in a disparity of practices. Therefore, the french

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0ba080a27cb3fa5e05795ac1e05da470
https://pubmed.ncbi.nlm.nih.gov/36052019

[Securing the information system of health care organisations]

Autor: B, Fleury, P, Loudenot, M, Suszko, S, Fourel, X, Kapola, J, Langrand-Escure, J-B, Guy

Publikováno v: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(6-7)

The information system involves all the resources managing information within a team. It mainly relies on the computer network. Prevention and protection measures are vital, especially in a radiotherapy department. They will aim to preserve the whole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f2f1823089af54d889bf1560664a4882
https://pubmed.ncbi.nlm.nih.gov/36057518

[Telemedicine for prostate cancer during long-term radiotherapy follow-up: An opportunity for digital innovation in oncology]

Autor: L, Suc, E, Daguenet, S, Louati, M, Gras, J, Langrand-Escure, S, Sotton, N, Magné

Publikováno v: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 25(1)

The annual follow-up in radiotherapy for prostate cancer consists of an oral interview with a radiation oncologist. The present study aimed at surveying the target population on their knowledge and perceptions of telemedicine.A prospective study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::39b31fef1ea0693b75fb66d09e8b0c45
https://pubmed.ncbi.nlm.nih.gov/33402288

Dose constraints for moderate hypofractionated radiotherapy for prostate cancer The French genito-urinary group (GETUG) recommendations

Autor: Gilles Créhange, C Llagostera, C Bonin, S. Belhomme, P. Sargos, R. de Crevoisier, Caroline Lafond, Christophe Hennequin, G. Delaroche, J Langrand-Escure, David Pasquier, Stéphane Supiot, I. Latorzeff, F Bideault

Publikováno v: Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2018, 22 (2), pp.193-198. ⟨10.1016/j.canrad.2017.11.004⟩
Cancer/Radiothérapie
Cancer/Radiothérapie, 2018, 22 (2), pp.193-198. ⟨10.1016/j.canrad.2017.11.004⟩
Cancer Radiothérapie, Elsevier Masson, 2018, 22 (2), pp.193-198

International audience; Considering recent phase III trials results, moderate hypofractionated radiotherapy can be considered as a standard treatment for low and intermediate risk prostate cancer management. This assessment call for a framework allow

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b3a3081382f62076bf25ed8d29933f
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01807361